Experimental vaccine trial aims to train immune system to fight childhood brain cancer
NCT ID NCT01795313
Summary
This early-stage study tested whether a personalized vaccine-like treatment could safely trigger immune responses against recurrent ependymoma brain tumors in children. The treatment combined tumor-specific protein fragments with an immune-boosting cream. The trial enrolled 23 children and young adults whose tumors had returned after standard treatments, but was terminated before completion.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPENDYMOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
Conditions
Explore the condition pages connected to this study.